Endocrinologists should take lead on thyroid eye disease care

The availability of new treatments for thyroid eye disease provides endocrinologists an opportunity to take the lead in managing the disease, according to an article published in AACE Endocrinology and Diabetes.
In decades past, thyroid eye disease was a challenging condition to treat due to the lack of therapy options outside of steroids, said Thanh D. Hoang, DO, MACP, FACE, professor of medicine at the Uniformed Services University of the Health Sciences. However, the FDA approval of teprotumumab-trbw (Tepezza, Amgen) in 2020 and veligrotug-vvze (Lumvoa, Viridian Therapeutics) in 2026 have

Vegetarian diet tied to lower risk for chronic kidney disease

Vegetarian diets may be linked to a lower risk for developing chronic kidney disease, according to study data published in Scientific Reports.
Previous studies have found associations between plant-based diets and lower risks for CKD, according to Catharina J. Candussi, MD, MSc, a PhD student at University of Vienna, and colleagues. However, population-based studies comparing these associations are more limited, they wrote.
“There is a lack of data examining habitual diet types in relation to CKD,” Candussi and colleagues wrote. “Habitual diet groups represent naturally occurring dietary

Immigrants with ischemic stroke face longer ICU stays

Immigrants and long-term residents of Canada, including citizens, with ischemic stroke had similar rates of ICU admissions, but immigrants had longer ICU stays, according to a study published in Neurology.
Higher rates of lifesaving treatments among immigrants may drive these differences in lengths of stay, Manav V. Vyas, MD, PhD, adjunct scientist at the Institute for Clinical and Evaluative Sciences, in Toronto, and colleagues wrote.
“The number of immigrants will increase or has increased over the years because of war, persecution and climate change,” Vyas, who also is a clinician scientist

Q&A: Navigating drug-free allergy nasal spray choices

Kenvue recently launched Zyrtec Allergen Shield Spray, joining Nasaleze and Becodefence as drug-free, over-the-counter nasal sprays designed for use before allergen exposure to stop allergens from causing symptoms.
According to the press release from Kenvue, individuals aged 12 years and older are protected for up to 6 hours after Zyrtec Allergen Shield Spray use. Similarly, Nasaleze and Becodefence (previously Prevalin) are recommended for use two to three times a day per their webpages.
Healio spoke with Priya Bansal, MD, FAAAAI, FACAAI, CEO of Asthma and Allergy Wellness Center,

GLP-1 use soars, bariatric surgery drops among teens, young adults

A retrospective analysis of more than 200,000 adolescents and young adults treated for obesity shows a significant increase in GLP-1 receptor agonist use since 2022, with a corresponding drop in metabolic and bariatric surgery.
“There’s a lot of really strong evidence-based data showing surgery is the most durable and effective intervention for severe obesity in both adults and adolescents,” Sarah E. Messiah, PhD, MPH, associate dean for research at O’Donnell School of Public Health and professor of epidemiology and pediatrics at UT Southwestern Medical Center, told Healio. “Most recently,

Study finds few avacopan-induced liver injury cases in US cohort

Elevations in liver enzymes were “uncommon” among a U.S. cohort treated with avacopan for ANCA-associated vasculitis, with 0.8% developing drug-induced liver injury, according to findings published in Arthritis & Rheumatology.
The study follows a drug safety communication released by the FDA in March identifying 76 cases of drug-induced liver injury (DILI) with causal links to avacopan (Tavneos, Amgen) — of which 66 occurred in Japan, while five were in the United States — including seven cases of vanishing bile duct syndrome. Of the 76 cases of DILI, eight were